Knowing your cancer risk and being proactive about your health may help you take steps to lower your risk for getting breast or ovarian cancer, or find it at an early stage. One in 40 Ashkenazi Jewish women has a BRCA gene mutation, compared to one in 500 women in the general population, putting them at an increased risk for breast cancer at a young age.Learn Your Family History of CancerAsking relatives about their cancer histories can be hard. Follow these tips:\u2022 Share that you have learned that cancers can run in families.\u2022 Explain that you are creating a record of your family\u2019s history of cancer.\u2022 Encourage family members to respond in a way that is most comfortable to them.\u2022 Word your questions carefully, be a ...
Abstract Inherited breast-ovarian cancer was described in 1866. The underlying genetic defects in BR...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Knowing your cancer risk and being proactive about your health may help you take steps to lower your...
Contains fulltext : 58980.pdf (publisher's version ) (Closed access)A family histo...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Everyone has BRCA genes, but some people have mutations (changes) in these genes which increase thei...
Women found to carry mutations in the BRCA1 or BRCA2 genes have up to an 88% lifetime risk of breast...
Women who have a mutation in the BRCA1 or BRCA2 genes have up to an 87% lifetime risk of breast canc...
AbstractNowadays, the major tasks of the increasing number of family cancer clinics are to provide g...
The recent identification of two breast and ovarian cancer susceptibility genes-BRCA1 and BRCA2- has...
Family history has long been recognized to be a potent risk factor for breast cancer [1]. Family his...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
One in nine women will develop breast cancer in her lifetime (Canadian Cancer Society, 2007). Heredi...
Objective: Ovarian cancer is the leading cause of gynecological death in the United States, and 14% ...
Abstract Inherited breast-ovarian cancer was described in 1866. The underlying genetic defects in BR...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Knowing your cancer risk and being proactive about your health may help you take steps to lower your...
Contains fulltext : 58980.pdf (publisher's version ) (Closed access)A family histo...
Breast cancer is the most common malignancy among women in the western world. Most cases are sporadi...
Everyone has BRCA genes, but some people have mutations (changes) in these genes which increase thei...
Women found to carry mutations in the BRCA1 or BRCA2 genes have up to an 88% lifetime risk of breast...
Women who have a mutation in the BRCA1 or BRCA2 genes have up to an 87% lifetime risk of breast canc...
AbstractNowadays, the major tasks of the increasing number of family cancer clinics are to provide g...
The recent identification of two breast and ovarian cancer susceptibility genes-BRCA1 and BRCA2- has...
Family history has long been recognized to be a potent risk factor for breast cancer [1]. Family his...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
One in nine women will develop breast cancer in her lifetime (Canadian Cancer Society, 2007). Heredi...
Objective: Ovarian cancer is the leading cause of gynecological death in the United States, and 14% ...
Abstract Inherited breast-ovarian cancer was described in 1866. The underlying genetic defects in BR...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...